Michel Duchosal

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


143 publications

2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1984 |
 
Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
Voruz S., Gowland P., Eyer C., Widmer N., Abonnenc M., Prudent M., Masouridi-Levrat S., Duchosal M.A., Niederhauser C., 2020/11. Blood transfusion = Trasfusione del sangue, 18 (6) pp. 446-453. Peer-reviewed.
 
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool.
Gerber A., Da Silva Lopes A., Szüts N., Simon M., Ribordy-Baudat V., Ebneter A., Perrinjaquet C., Gaignard M.E., Nicodet D., Betticher D. et al., 2020/06. Health science reports, 3 (2) pp. e160. Peer-reviewed.
 
L’hématologie au temps du COVID-19 [Hematology in the time of COVID-19]
Gavillet M., Rufer N., Grandoni F., Carr Klappert J., Zermatten M.G., Cairoli A., Canellini G., Alberio L., Duchosal M.A., Spertini O. et al., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 823-826. Peer-reviewed.
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.
Cloux A.J., Aubry D., Heulot M., Widmann C., ElMokh O., Piacente F., Cea M., Nencioni A., Bellotti A., Bouzourène K. et al., 2019/11/19. Oncotarget, 10 (62) pp. 6723-6738. Peer-reviewed.
 
Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.
Samaras P., Bargetzi M., Betticher D.C., Driessen C., Duchosal M.A., Heim D., Ketterer N., Lerch E., Matthes T., Mey U. et al., 2019/03/25. Swiss medical weekly, 149 pp. w20031. Peer-reviewed.
 
The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance.
Vannini N., Campos V., Girotra M., Trachsel V., Rojas-Sutterlin S., Tratwal J., Ragusa S., Stefanidis E., Ryu D., Rainer P.Y. et al., 2019/03/07. Cell stem cell, 24 (3) pp. 405-418.e7. Peer-reviewed.
Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives.
De Goycoechea D., Stalder G., Martins F., Duchosal M.A., 2019. Journal of oncology, 2019 p. 9513701. Peer-reviewed.
 
Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Bischoff-Ferrari H.A., Boggian K., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H., Hirzel C., Manuel O. et al., 2019/01. Transplant international, 32 (1) pp. 49-58. Peer-reviewed.
 
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
Kuster S., Stampf S., Gerber B., Baettig V., Weisser M., Gerull S., Medinger M., Passweg J., Schanz U., Garzoni C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12981. Peer-reviewed.
Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D., Hirzel C., Boely E., Lecompte T., Khanna N., Mueller N.J., Boggian K., Cusini A., Manuel O., van Delden C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12984. Peer-reviewed.
 
New-onset obesity after liver transplantation-outcomes and risk factors: the Swiss Transplant Cohort Study.
Beckmann S., Denhaerynck K., Stampf S., Saigi-Morgui N., Binet I., Koller M., Boely E., De Geest S., Psychosocial Interest Group, Swiss Transplant Cohort Study, 2018/11. Transplant international, 31 (11) pp. 1254-1267. Peer-reviewed.
Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.
Pellegrin M., Bouzourène K., Aubert J.F., Nahimana A., Duchosal M.A., Mazzolai L., 2018/09/04. International journal of molecular sciences, 19 (9) pp. E2621. Peer-reviewed.
 
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Neofytos D., Chatzis O., Nasioudis D., Boely Janke E., Doco Lecompte T., Garzoni C., Berger C., Cussini A., Boggian K., Khanna N. et al., 2018/08. Transplant infectious disease, 20 (4) pp. e12898. Peer-reviewed.
 
Les lymphohistiocytoses hémophagocytaires [Hemophagocytic Lymphohistiocytosis]
Stalder G., Ribi C., Duchosal M.A., 2018/08. Praxis, 107 (16) pp. 902-911. Peer-reviewed.
 
Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
Cusini A., Béguelin C., Stampf S., Boggian K., Garzoni C., Koller M., Manuel O., Meylan P., Mueller N.J., Hirsch H.H. et al., 2018/07. American journal of transplantation, 18 (7) pp. 1745-1754. Peer-reviewed.
 
Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
Bello C., Bai J., Zambron B.K., Elías-Rodríguez P., Gajate C., Robina I., Caffa I., Cea M., Montecucco F., Nencioni A. et al., 2018/04/25. European journal of medicinal chemistry, 150 pp. 457-478. Peer-reviewed.
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
Cagnetta A., Soncini D., Orecchioni S., Talarico G., Minetto P., Guolo F., Retali V., Colombo N., Carminati E., Clavio M. et al., 2018/01. Haematologica, 103 (1) pp. 80-90. Peer-reviewed.
 
Diagnosis and treatment of follicular lymphoma: an update.
Bargetzi M., Baumann R., Cogliatti S., Dietrich P.Y., Duchosal M., Goede J., Hitz F., Konermann C., Lohri A., Mey U. et al., 2018. Swiss medical weekly, 148 pp. w14635. Peer-reviewed.
Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
Passweg J.R., Baldomero H., Ansari M., Baerlocher G.M., Bargetzi M., Chalandon Y., Duchosal M.A., Gerull S., Güngör T., Halter J.P. et al., 2018. Swiss medical weekly, 148 pp. w14589. Peer-reviewed.
Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation.
Chennupati V., Veiga D.F., Maslowski K.M., Andina N., Tardivel A., Yu E.C., Stilinovic M., Simillion C., Duchosal M.A., Quadroni M. et al., 2018. The Journal of Clinical Investigation, 128 (4) pp. 1597-1614. Peer-reviewed.
 
BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.
Leboeuf C., Wilk S., Achermann R., Binet I., Golshayan D., Hadaya K., Hirzel C., Hoffmann M., Huynh-Do U., Koller M.T. et al., 2017/10. American journal of transplantation, 17 (10) pp. 2591-2600. Peer-reviewed.
T315I clone selection in a Ph+ all patient under low-dose ponatinib maintenance.
Noetzli J., Gavillet M., Masouridi-Levrat S., Duchosal M., Spertini O., 2017/08. Clinical case reports, 5 (8) pp. 1320-1322. Peer-reviewed.
 
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Piacente F., Caffa I., Ravera S., Sociali G., Passalacqua M., Vellone V.G., Becherini P., Reverberi D., Monacelli F., Ballestrero A. et al., 2017/07/15. Cancer research, 77 (14) pp. 3857-3869. Peer-reviewed.
 
Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
Martin-Gandul C., Stampf S., Héquet D., Mueller N.J., Cusini A., van Delden C., Khanna N., Boggian K., Hirzel C., Soccal P. et al., 2017/07. American journal of transplantation, 17 (7) pp. 1813-1822. Peer-reviewed.
 
Torque Teno Virus Load and Acute Rejection After Orthotopic Liver Transplantation.
Simonetta F., Pradier A., Masouridi-Levrat S., van Delden C., Giostra E., Morard I., Mueller N., Muellhaupt B., Valli P.V., Semmo N. et al., 2017/07. Transplantation, 101 (7) pp. e219-e221. Peer-reviewed.
 
Evolution of body weight parameters up to 3 years after solid organ transplantation: The prospective Swiss Transplant Cohort Study.
Beckmann S., Nikolic N., Denhaerynck K., Binet I., Koller M., Boely E., De Geest S., Psychosocial Interest Group Swiss Transplant Cohort Study, 2017/03. Clinical transplantation, 31 (3). Peer-reviewed.
 
ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study.
Mauthner O., Claes V., Walston J., Engberg S., Binet I., Dickenmann M., Golshayan D., Hadaya K., Huynh-Do U., Calciolari S. et al., 2017/03. Journal of advanced nursing, 73 (3) pp. 716-734. Peer-reviewed.
 
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison.
Baumgartner A., Bargetzi M., Bargetzi A., Zueger N., Medinger M., Passweg J., Schanz U., Samaras P., Chalandon Y., Pichard C. et al., 2017/03. Nutrition, 35 pp. 43-50. Peer-reviewed.
 
Gray platelet syndrome: Novel mutations of the NBEAL2 gene.
Bottega R., Nicchia E., Alfano C., Glembotsky A.C., Pastore A., Bertaggia-Calderara D., Bisig B., Duchosal M.A., Arbesú G., Alberio L. et al., 2017/02. American journal of hematology, 92 (2) pp. E20-E22. Peer-reviewed.
Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.
Beaume M., Köhler T., Greub G., Manuel O., Aubert J.D., Baerlocher L., Farinelli L., Buckling A., van Delden C., Swiss Transplant Cohort Study, 2017/01/17. Scientific reports, 7 p. 40309. Peer-reviewed.
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L., Bochud P.Y., Golshayan D., Crettol S., Venetz J.P., Manuel O., Kutalik Z., Treyer A., Lehmann R., Mueller N.J. et al., 2017/01. The pharmacogenomics journal, 17 (1) pp. 69-75. Peer-reviewed.
 
HIV-Positive-to-HIV-Positive Liver Transplantation.
Calmy A., van Delden C., Giostra E., Junet C., Rubbia Brandt L., Yerly S., Chave J.P., Samer C., Elkrief L., Vionnet J. et al., 2016/08. American journal of transplantation, 16 (8) pp. 2473-2478. Peer-reviewed.
 
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.
Golshayan D., Wójtowicz A., Bibert S., Pyndiah N., Manuel O., Binet I., Buhler L.H., Huynh-Do U., Mueller T., Steiger J. et al., 2016/04. Kidney international, 89 (4) pp. 927-938. Peer-reviewed.
 
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky D.J., Abdelmohsen K., Abe A., Abedin M.J., Abeliovich H., Acevedo Arozena A., Adachi H., Adams C.M., Adams P.D., Adeli K. et al., 2016/01. Autophagy, 12 (1) pp. 1-222.
Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis.
Stalder G., Que Y.A., Calzavarini S., Burnier L., Kosinski C., Ballabeni P., Roger T., Calandra T., Duchosal M.A., Liaudet L. et al., 2016. PloS one, 11 (10) pp. e0163542. Peer-reviewed.
Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
Héquet D., Kralidis G., Carrel T., Cusini A., Garzoni C., Hullin R., Meylan P.R., Mohacsi P., Mueller N.J., Ruschitzka F. et al., 2016. Bmc Infectious Diseases, 16 p. 321. Peer-reviewed.
 
Combinative effects of β-Lapachone and APO866 on pancreatic cancer cell death through reactive oxygen species production and PARP-1 activation.
Breton C.S., Aubry D., Ginet V., Puyal J., Heulot M., Widmann C., Duchosal M.A., Nahimana A., 2015. Biochimie, 116 pp. 141-153. Peer-reviewed.
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
Samaras P., Bargetzi M., Betticher D.C., Duchosal M.A., Heim D., Hess U., Ketterer N., Lerch E., Matthes T., Mey U. et al., 2015. Swiss Medical Weekly, 145 pp. w14100. Peer-reviewed.
 
Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes.
Schmied L., Terszowski G., Gonzalez A., Schmitter K., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C. et al., 2015. Transplantation, 99 (12) pp. 2651-2655. Peer-reviewed.
 
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Hirsch H. et al., 2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 (4) pp. 619-622. Peer-reviewed.
Reply to Cunha et al.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Khanna N. et al., 2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 (12) pp. 1894-1895. Peer-reviewed.
The potential use of microcalorimetry in rapid differentiation between septic arthritis and other causes of arthritis.
Yusuf E., Hügle T., Daikeler T., Voide C., Borens O., Trampuz A., 2015. European Journal of Clinical Microbiology and Infectious Diseases, 34 (3) pp. 461-465. Peer-reviewed.
A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesis.
Ginet V., Puyal J., Rummel C., Aubry D., Breton C., Cloux A.J., Majjigapu S.R., Sordat B., Vogel P., Bruzzone S. et al., 2014. Autophagy, 10 (4) pp. 603-617.
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies.
Breton C.S., Nahimana A., Aubry D., Macoin J., Moretti P., Bertschinger M., Hou S., Duchosal M.A., Back J., 2014. Journal of Hematology and Oncology, 7 p. 33. Peer-reviewed.
 
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.
Gotta V., Widmer N., Decosterd L.A., Chalandon Y., Heim D., Gregor M., Benz R., Leoncini-Franscini L., Baerlocher G.M., Duchosal M.A. et al., 2014. Cancer Chemotherapy and Pharmacology, 74 (6) pp. 1307-1319. Peer-reviewed.
 
High-dose therapy and autologous hematopoietic stem cell transplant in T-cell lymphoma: a single center experience.
Cairoli A., Ketterer N., Barelli S., Duchosal M.A., 2014. Leukemia and Lymphoma, 55 (8) pp. 1827-1831.
 
The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody.
Nahimana A., Aubry D., Breton C.S., Majjigapu S.R., Sordat B., Vogel P., Duchosal M.A., 2014. Leukemia and Lymphoma, 55 (9) pp. 2141-2150.
 
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.
Jantunen E., Boumendil A., Finel H., Luan J.J., Johnson P., Rambaldi A., Haynes A., Duchosal M.A., Bethge W., Biron P. et al., 2013. Blood, 121 (13) pp. 2529-2532.
 
Clinical pharmacokinetics of imatinib and its therapeutic relevance
Widmer N., Gotta V., Haouala A., Blanc J., von Mehren M., Duchosal M., Leyvraz S., Csajka C., Decosterd L.A., Buclin T., 2013. pp. 15-43 dans Akhtari M., Elhemaidi I. (eds.) Imatinib: Chemical structure, pharmacology and adverse effects chap. 2, Nova Science Publishers.
 
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: Results from the randomized controlled I-COME Trial
Gotta V., Widmer N., Decosterd L.A., Chalandon Y., Heim D., Benz R., Gregor M., Leoncini-Franscini L., Baerlocher G., Duchosal M. et al., 2013. pp. e6 dans 11th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Clinical Therapeutics. Peer-reviewed.
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries.
Passweg J.R., Baldomero H., Bargetzi M., Bucher C., Chalandon Y., Duchosal M.A., Gratwohl A., Güngör T., Hess U., Leibundgut K. et al., 2013. Swiss Medical Weekly, 143 (143) pp. w13757.
 
Myélome multiple : diagnostic et perspectives thérapeutiques
Cairoli A., Duchosal M.A., 2013. Swiss Medical Forum = Forum Médical Suisse, 13 (38) pp. 746-751.
Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine.
Gavillet M., Noetzli J., Blum S., Duchosal M.A., Spertini O., Lambert J.F., 2012/12. Haematologica, 97 (12) pp. 1929-1931. Peer-reviewed.
 
Guidelines for the use and interpretation of assays for monitoring autophagy.
Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A. et al., 2012/04. Autophagy, 8 (4) pp. 445-544. Peer-reviewed.
 
Autologous Stem Cell Transplantation (ASCT) for Enteropathy-Associated T-Cell Lymphoma (EATL): Final Analysis of a Retrospective Study On the Behalf of Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).
Jantunen E., Boumendil A., Finel H., Luan J.J., Johnson P.R.E, Rambaldi A., Haynes A., Duchosal M.A., Kanz L., Biron P. et al., 2012. pp. Abstract 3105 dans ASH 2012, 54th Annual Meeting of the American Society of Hematology, Blood.
Gammapathies monoclonales: Utilisation des chaînes légères libres sériques.
Aubert V., Duchosal M.A., 2012. Swiss Medical Forum, 12 (29) pp. 576-577.
 
Pharmacokinetic (PK)-based dosage individualization of imatinib: evaluation of efficiency and clinical usefulness
Gotta V., Widmer N., Decosterd L.A., Montemurro M., Leyvraz S., Chalandon Y., Heim D., Gregor M., Benz R., Leoncini-Franscini L. et al., 2012. dans 3rd Symposium of the Swiss Clinical Trial Organisation (SCTO), Personalised Medicine in Clinical Research.
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
Mise en place percutanée de filtres dans la veine cave inférieure en prévention de l'embolie pulmonaire : recommandations
Mazzolai L., Qanadli S., 2011/04. 7 p..
A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants
Nahimana A., Aubry D., Lagopoulos L., Greaney P., Attinger A., Demotz S., Dawson K.M., Schapira M., Tschopp J., Dupuis M. et al., 2011. Blood Cancer Journal, 1 (12) pp. e47.
 
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.
Bello C., Dal Bello G., Cea M., Nahimana A., Aubry D., Garuti A., Motta G., Moran E., Fruscione F., Pronzato P. et al., 2011. Bioorganic and Medicinal Chemistry, 19 (24) pp. 7720-7727.
 
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib.
Haouala A., Widmer N., Duchosal M.A., Montemurro M., Buclin T., Decosterd L.A., 2011. Blood, 117 (8) pp. e75-e87. Peer-reviewed.
 
Growth arrest-specific gene 6 (GAS6) as an intra-hospital mortality predictor for patients in septic shock
Stalder G., Kosinski C., Delodder F., Ternon B., Roger T., Calandra T., Duchosal M.A., Eggimann P., Angelillo-Scherrer A., 2011. p. 14 dans ISTH 2011, 23rd Congress of the International Society on Thrombosis and Haemostasis, 57th Annual SSC Meeting (Scientific and Standardization Committee), Journal of Thrombosis and Haemostasis. Peer-reviewed.
Recommendations pour le diagnostic et le traitement de la leucémie lymphoïde chronique en Suisse. 1ère partie : Diagnostic, stadification et facteurs pronostiques
Gregor M., Bargetzi M., Duchosal M.A., Goede J.S., Heim D., Helg C., Korte W., Leoncini L., Solenthaler M., Zenhäusern R., 2011. Forum Médical Suisse, 11 (6) pp. 93-97.
Recommendations pour le diagnostic et le traitement de la leucémie lymphoïde chronique en Suisse. 2ème partie : Indications et stratégies thérapeutiques
Gregor M., Bargetzi M., Duchosal M.A., Goede J.S., Heim G., Helg C., Korte W., Leoncini L., Solenthaler M., Zenhäusern R., 2011. Forum Médical Suisse, 11 (7) pp. 118-124.
Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect.
Passweg J., Baldomero H., Stern M., Bargetzi M., Ghielmini M., Leibundgut K., Duchosal M., Hess U., Seger R., Buhrfeind E. et al., 2010/06/12. Swiss medical weekly, 140 (23-24) pp. 326-334. Peer-reviewed.
 
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
Bello C., Cea M., Dal Bello G., Garuti A., Rocco I., Cirmena G., Moran E., Nahimana A., Duchosal M.A., Fruscione F. et al., 2010/05/01. Bioorganic & medicinal chemistry, 18 (9) pp. 3320-3334. Peer-reviewed.
 
Absence of residual Hodgkin's disease demonstrated by PET/CT in a deceased organ donor.
Prior J.O., Duchosal M.A., Schmidt S., Turini P., Pilon N., Chioléro R., Pascual M., 2010/01. Transplant international, 23 (1) pp. 101-104. Peer-reviewed.
 
Anémie
Richard N., Pasche O., Favrat B., Cornuz J., Duchosal M., 2010. pp. 83-96 dans Cornuz J., Pasche O. (eds.) Compas : stratégies de prise en charge clinique : médecine interne générale ambulatoire, Médecine et Hygiène.
 
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma.
Tenan M., Aurrand-Lions M., Widmer V., Alimenti A., Burkhardt K., Lazeyras F., Belkouch M.C., Hammel P., Walker P.R., Duchosal M.A. et al., 2010. Glia, 58 (5) pp. 524-537. Peer-reviewed.
 
Feasibility of Therapeutic Drug Monitoring (TDM) for Imatinib: Preliminary considerations on the dosage adjustment approach for CML patients enrolled in the Imatinib Concentration Monitoring (I-COME) study
Gotta V., Widmer N., Decosterd L.A., Csajka C., Duchosal M.A., Chalandon Y., Heim D., Gregor M., Buclin T., 2010. pp. 90S dans 78. Jahresversammlung der Schweizerischen Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
 
Recommendations for the diagnosis and treatment of myelodysplastic syndromes in adult patients in Switzerland
Passweg J.R., Duchosal M.A., Hess U., Blum S., Freiburghaus A.U., Bargetzi M., Binder D., Dirnhofer St., Friess D., Goede J.S. et al., 2010. Swiss Medical Forum = Forum Médical Suisse, 10 (15) pp. 259-265.
Suivi thérapeutique de l'imatinib
Gotta V., Widmer N., Decosterd L.A., Csajka C., Duchosal M.A., Chalandon Y., Heim D., Gregor M., Buclin T., 2010. Forum Medical Suisse, 10 (23) pp. 403-406. Peer-reviewed.
 
Therapeutic Drug Monitoring (TDM) of Imatinib: Effectiveness of Bayesian dose adjustment for CML patients enrolled in the Imatinib Concentration Monitoring (I-COME) study
Gotta V., Widmer N., Decosterd L.A., Csajka C., Duchosal M.A., Chalandon Y., Heim D., Gregor M., Buclin T., 2010. pp. 28S dans Réunion annuelle Société Suisse de Médecine Intensive, Société Suisse d'Infectiologie, Société Suisse d'Hygiène Hospitalière, Société Suisse de Pharmacologie et Toxicologie Cliniques, Communauté Suisse d'intérêts pour soins intensifs, Invité: Société Suisse de Transplantation, Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
 
Hémopathie maligne: prise en charge de l'anémie et de la leucopénie par le médecin de premier recours [Hematological malignancy: management of anemia and leukopenia by primary care physicians]
Burnand J., Waeber G., Duchosal M.A., 2009/10/28. Revue medicale suisse, 5 (223) pp. 2147-2148,2150-2152,2154-2155. Peer-reviewed.
 
Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
Rosselet A., Vu D.H., Meylan P., Chaubert A.S., Schapira M., Pascual M., Aubert V., Tissot J.D., Duchosal M.A., 2009. Clinical Transplantation, 23 (1) pp. 74-82.
Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
Frossard V., Ketterer N., Rosselet A., Meier P., Cairoli A., Duchosal M.A., Kovacsovics T., 2009. Annals of Hematology, 88 (7) pp. 681-685.
 
IFNalpha activates dormant haematopoietic stem cells in vivo.
Essers M.A., Offner S., Blanco-Bose W.E., Waibler Z., Kalinke U., Duchosal M.A., Trumpp A., 2009. Nature, 458 (7240) pp. 904-908. Peer-reviewed.
 
NAD targeting efficiently kills hematologic cancer cells [Response]
Nahimana A., Aubry D., Butcher S., Duchosal M. A., 2009. Blood, 113 (23) pp. 6037-6038. Peer-reviewed.
 
The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies.
Nahimana A., Attinger A., Aubry D., Greaney P., Ireson C., Thougaard A.V., Tjørnelund J., Dawson K.M., Dupuis M., Duchosal M.A., 2009. Blood, 113 (14) pp. 3276-3286.
 
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A., Zanolari B., Rochat B., Montemurro M., Zaman K., Duchosal M.A., Ris H.B., Leyvraz S., Widmer N., Decosterd L.A., 2009. Journal of Chromatography. B, 877 (22) pp. 1982-1996. Peer-reviewed.
Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome
Dietrich P. Y., Duchosal M. A., 2008/01. Annals of Oncology, 19 (3) p. 595. Peer-reviewed.
 
Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E., Pascual M., Nicod M., Delaloye A.B., Duchosal M.A., 2008. Transplantation, 85 (5) pp. 707-712. Peer-reviewed.
 
Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome?
Cuttelod M., Pascual A., Baur Chaubert A.S., Cometta A., Osih R., Duchosal M.A., Cavassini M., 2008. AIDS, 22 (4) pp. 549-551.
 
Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Laffitte E., Venetz J.P., Aubert J.D., Duchosal M.A., Panizzon R.G., Pascual M., 2008. Dermatology, 217 (1) pp. 87-88.
Radiological profile of anemia on unenhanced MDCT of the thorax.
Kamel E.M., Rizzo E., Duchosal M.A., Duran R., Goncalves-Matoso V., Schnyder P., Qanadli S.D., 2008. European Radiology, 18 (9) pp. 1863-1868. Peer-reviewed.
Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability
Widmer N., Decosterd L. A., Leyvraz S., Duchosal M. A., Rosselet A., Debiec-Rychter M., Csajka C., Biollaz J., Buclin T., 2008. British Journal of Cancer, 98 (10) pp. 1633-1640. Peer-reviewed.
 
Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening
Mazzolai L., Duchosal M. A., 2007/10. European Journal of Vascular and Endovascular Surgery, 34 (4) pp. 483-488.
 
Clinical consequences of imatinib plasma concentrations variability in hemato-oncologic patients
Widmer N., Leyvraz S., Duchosal M.A., Rosselet A., Csajka C., Henry H., Debiec-Rychter M., Eap C.B., Biollaz J., Buclin T. et al., 2007. p. 481 dans 10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), Therapeutic Drug Monitoring. Peer-reviewed.
 
Functionnal significance of active dye exclusion by human hemtopoeitic progenitors after short-terme culture
Kindler V., Duchosal M.A., von Planta M., Vallet V., Suva D., Soulas C., 2007. Journal of stem cells, 2 (1) pp. 1-13.
 
Hématologie: Syndromes myéloprolifératifs - une kinase après l'autre
Lambert J.F., Duchosal M.A., 2007. Swiss Medical Forum = Forum Médical Suisse, 7 (1) pp. 11-13.
 
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-up.
Bessoud B., Duchosal M.A., Siegrist C.A., Schlegel S., Doenz F., Calmes J.M., Qanadli S.D., Schnyder P., Denys A., 2007. Journal of Trauma, 62 (6) pp. 1481-1486.
 
Relations entre les taux plasmatiques d'imatinib et ses effets cliniques
Widmer N., Decosterd L.A., Leyvraz S., Duchosal M.A., Rosselet A., Debiec-Rychter M., Csajka C., Biollaz J., Buclin T., 2007. dans 14es Journées Franco-Suisses de Pharmacie Hospitalière.
 
Relationships between imatinib plasma levels and efficacy
Widmer N., Decosterd L.A., Leyvraz S., Duchosal M.A., Rosselet A., Debiec-Rychter M., Csajka C., Biollaz J., Buclin T., 2007. pp. 80S dans 75. Jahresversammlung der Schweizerisches Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
 
Traitement de la leucémie myéloïde chronique 2007: Recommandations du groupe suisse de travail de la LMC [Treatment of CML in 2007 : Recommendations of a Swiss expert panel]
Gratwohl A., Heim D., Bergetzi M., Baerlocher G.M., Chalandon Y., Duchosal M.A., Gregor M., Hess U., Oppliger Leibundgut E., Passweg J. et al., 2007. Swiss Medical Forum = Forum Médical Suisse, 7 (46) pp. 934-940.
 
Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy
Mazzolai L., Hohlfeld P., Spertini F., Hayoz D., Schapira M., Duchosal M. A., 2006/09. Blood, 108 (5) pp. 1569-1570.
 
A Fas agonist induces high levels of apoptosis in haematological malignancies
Greaney P., Nahimana A., Lagopoulos L., Etter A. L., Aubry D., Attinger A., Beltraminelli N., Huni B., Bassi I., Sordat B. et al., 2006/04. Leukemia Research, 30 (4) pp. 415-426.
 
Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein
Widmer N., Decosterd L.A., Csajka C., Leyvraz S., Duchosal M.A., Rosselet A., Rochat B., Eap C.B., Henry H., Biollaz J. et al., 2006. British journal of clinical pharmacology, 62 (1) pp. 97-112. Peer-reviewed.
 
Relations entre la pharmacocinétique de population de l'imatinib et l'alpha-1-glycoproteine acide chez des patients hémato-oncologiques
Widmer N., Decosterd L.A., Csajka C., Leyvraz S., Duchosal M.A., Rosselet A., Rochat B., Eap C.B., Henry H., Biollaz J. et al., 2006. dans 13es Journées Franco-Suisses de Pharmacie Hospitalière.
 
Relationship between imatinib population pharmacokinetics and alpha-1-acid glycoprotein
Widmer N., Decosterd L.A., Csajka C., Leyvraz S., Duchosal M.A., Rosselet A., Rochat B., Eap C.B., Henry H., Biollaz J. et al., 2006. pp. 71S dans 74e Assemblée annuelle de la Société Suisse de Médecine Interne (SSMI), Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
 
Human tonsil implants xenotransplanted in SCID mice display broad lymphocytic diversity and cellular activation profile similar to those in the original lymphoid organ.
Vallet V., Mauray S., Kindler V., Aubry D., Ruegg M., Cherpillod J., Waridel F., Schapira M., Duchosal M.A., 2005. Xenotransplantation, 12 (1) pp. 38-48.
 
Population pharmacokinetics of imatinib in CML and GIST patients under long-term treatment
Widmer N., Decosterd L.A., Leyvraz S., Duchosal M.A., Csajka C., Biollaz J., Buclin T., 2005. pp. 116-117 dans 7th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Basic and Clinical Pharmacology and Toxicology. Peer-reviewed.
 
Population pharmacokinetics of imatinib in CML and GIST patients under long-term treatment
Widmer N., Decosterd L.A., Leyvraz S., Duchosal M.A., Csajka C., Biollaz J., Buclin T., 2005. pp. 63S dans 73e Assemblée annuelle de la Société Suisse de Médecine Interne (SSMI), Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
 
Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia
Gambillara E., Laffitte E., Widmer N., Decosterd L. A., Duchosal M. A., Kovacsovics T., Panizzon R. G., 2005. Dermatology, 211 (4) pp. 363-365. Peer-reviewed.
 
Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection
Widmer N., Beguin A., Rochat B., Buclin T., Kovacsovics T., Duchosal M. A., Leyvraz S., Rosselet A., Biollaz J., Decosterd L. A., 2004/04. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 803 (2) pp. 285-292. Peer-reviewed.
 
A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.
Perrenoud G., Messerli F., Thierry A.C., Beltraminelli N., Cousin P., Fasel N., Vallet V., Demotz S., Duchosal M.A., Moulon C., 2004. Vaccine, 23 (4) pp. 480-488.
 
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Mazzolai L., Duchosal M.A., Korber M., Bouzourene K., Aubert J.F., Hao H., Vallet V., Brunner H.R., Nussberger J., Gabbiani G. et al., 2004. Hypertension, 44 (3) pp. 277-82.
 
Proteomic studies of human lymphocytes: New insights into HIV lymphocyte infection ?
Vuadens F., Crettaz D., Telenti A., Quadroni M., Duchosal M. A., Schneider P., Tissot J. D., 2004. pp. 245-262 dans Sanchez J.C., Corthals G.L., Hochstrasser D.F (eds.) Biomedical Applications of Proteomics, Wiley.
 
Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens
Pihlgren M., Tougne C., Bozzotti P., Fulurija A., Duchosal M. A., Lambert P. H., Siegrist C. A., 2003/03. Journal of Immunology, 170 (6) pp. 2824-2832.
 
Fate and functions of human adult lymphoid cells in immunodeficient mice
Vallet V., Cherpillod J., Waridel F., Duchosal M. A., 2003/01. Histology and Histopathology, 18 (1) pp. 309-322.
 
The immunoglobulinopathies: from physiopathology to diagnosis
Tissot J. D., Vu D. H., Aubert V., Schneider P., Vuadens F., Crettaz D., Duchosal M. A., 2002/07. Proteomics, 2 (7) pp. 813-824.
 
IgM are associated to Sp alpha (CD5 antigen-like)
Tissot J. D., Sanchez J. C., Vuadens F., Scherl A., Schifferli J. A., Hochstrasser D. F., Schneider P., Duchosal M. A., 2002/04. Electrophoresis, 23 (7-8) pp. 1203-1206.
 
Human peripheral blood leukocyte engraftment into SCID mice: critical role of CD4(+) T cells
Duchosal M. A., Mauray S., Ruegg M., Trouillet P., Vallet V., Aarden L., Tissot J. D., Schapira M., 2001/07. Cellular Immunology, 211 (1) pp. 8-20.
 
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
Mauray S., Fuzzati-Armentero M. T., Trouillet P., Ruegg M., Nicoloso G., Hart M., Aarden L., Schapira M., Duchosal M. A., 2000/07. European Journal of Immunology, 30 (7) pp. 2065-2073.
 
The diversity of antigen-specific antibodies in humans and in two xenochimeric SCID mouse models
Layer A., Tissot J. D., Schneider P., Duchosal M. A., 2000/07. Electrophoresis, 21 (12) pp. 2463-2475.
 
Human adult tonsil xenotransplantation into SCID mice for studying human immune responses and B cell lymphomagenesis
Duchosal M. A., Fuzzati-Armentero M. T., Baccala R., Layer A., Gonzalez-Quintial R., Leturcq D., Ruegg M., Trouillet P., Mauray S., Tissot J. D. et al., 2000/02. Experimental Hematology, 28 (2) pp. 177-92.
 
Essential guides for isolation/purification of immunoglobulins
Layer A., Schneider P., Tissot J.D., Duchosal M.A., 2000. pp. 4553-4559 dans Wilson I.D., Adlar E.R., Cook M., Poole C.F. (eds.) Encyclopedia of Separation Science, Academic Press.
 
Two-dimensional polyacrylamide gel electrophoresis
Tissot J. D., Schneider P., Duchosal M. A., 2000. pp. 1364-1371 dans Wilson I.D., Adlar E.R., Cook M., Poole C.F. (eds.) Encyclopedia of Separation Science, London Academic Press.
 
Micropurification and two-dimensional polyacrylamide gel electrophoresis of immunoglobulins for studying the clonal diversity of antigen-specific antibodies
Layer A., Tissot J. D., Schneider P., Duchosal M. A., 1999/07. Journal of Immunological Methods, 227 (1-2) pp. 137-148.
 
Principes de la transplantation de cellules souches hématopoïétiques dans les maladies auto-immunes
Duchosal M. A., Tissot J. D., 1999. Médecine et Hygiène, 57 (2253) pp. 916-922.
 
hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease
Fuzzati-Armentero M. T., Duchosal M. A., 1998/01. Histology and Histopathology, 13 (1) pp. 155-168.
 
B-cell development and differentiation
Duchosal M. A., 1997/01. Seminars in Hematology, 34 (1 Suppl 1) pp. 2-12.
 
In vivo immunosuppression by targeting a novel protease receptor
Duchosal M. A., Rothermel A. L., McConahey P. J., Dixon F. J., Altieri D. C., 1996/03. Nature, 380 (6572) pp. 352-356.
 
Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation
Tissot J. D., Schneider P., Schapira M., Duchosal M. A., 1996/02. Cellular Immunology, 167 (2) pp. 241-248. Peer-reviewed.
 
Les "immunoglobinopathies " : gammapathies monoclonales et oligoclonales
Tissot J. D., Duchosal M. A., 1996. Médecine et Hygiène, 54 (2116) pp. 957-961.
 
Two-dimensional electrophoresis as an aid in the analysis of the clonality of immunoglobulins
Tissot J. D., Schneider P., Hohlfeld P., Spertini F., Hochstrasser D. F., Duchosal M. A., 1993/12. Electrophoresis, 14 (12) pp. 1366-1371.
 
Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.
Pascual M., Duchosal M.A., Steiger G., Giostra E., Pechère A., Paccaud J.P., Danielsson C., Schifferli J.A., 1993. Journal of Immunology, 151 (3) pp. 1702-1711. Peer-reviewed.
 
Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease
Duchosal M. A., Eming S. A., McConahey P. J., Dixon F. J., 1992/11. American Journal of Pathology, 141 (5) pp. 1097-1113.
 
The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice
Duchosal M. A., Eming S. A., McConahey P. J., Dixon F. J., 1992/02. Cellular Immunology, 139 (2) pp. 468-477.
 
Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries
Duchosal M. A., Eming S. A., Fischer P., Leturcq D., Barbas, C. F., 3rd , McConahey P. J., Caothien R. H., Thornton G. B., Dixon F. J., Burton D. R., 1992/01. Nature, 355 (6357) pp. 258-262.
 
SCID mice in the study of human autoimmune diseases
Duchosal M. A., 1992. Springer Seminars in Immunopathology, 14 (2) pp. 159-177.
 
Use of immunized hu-PBL-SCID mice and repertoire cloning to generate specific human monoclonal Fab fragments
Duchosal M., Eming S.A, Fischer P., Letrucq D., Bardas C.F., McConahey P.J., Caothien R.H., Thornton G.B., Dixon F.J., Burton D.R., 1992. Vaccines : CHS Lab Press, 19 pp. 19-24.
 
An autosomal recessive gene that delays expression of lupus in BXSB mice
Kofler R., McConahey P. J., Duchosal M. A., Balderas R. S., Theofilopoulos A. N., Dixon F. J., 1991/02. Journal of Immunology, 146 (4) pp. 1375-1379.
 
Autoimmune syndrome after neonatal induction of tolerance to alloantigens: analysis of the specificity and of the cellular and genetic origin of autoantibodies
Schurmans S., Merino J., Qin H. Y., Kramar G., Duchosal M., Skalli O., Benzonana G., Gabbiani G., Lambert P. H., 1991. Autoimmunity, 9 (4) pp. 283-291.
Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice
Duchosal M. A., McConahey P. J., Robinson C. A., Dixon F. J., 1990/09. Journal of Experimental Medicine, 172 (3) pp. 985-988.
 
Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells
Merino J., Schurmans S., Duchosal M. A., Izui S., Lambert P. H., 1989/10. Journal of Immunology, 143 (7) pp. 2202-2208.
 
Genetic diversity of murine rheumatoid factors
Duchosal M. A., Kofler R., Balderas R. S., Aguado M. T., Dixon F. J., Theofilopoulos A. N., 1989/03. Journal of Immunology, 142 (5) pp. 1737-1742.
 
B and T cell antigen receptor repertoires in lupus/arthritis murine models
Theofilopoulos A. N., Singer P. A., Kofler R., Kono D. H., Duchosal M. A., Balderas R. S., 1989. Springer Seminars in Immunopathology, 11 (3) pp. 335-368.
 
Complexity, polymorphism, and connectivity of mouse Vk gene families
Kofler R., Duchosal M. A., Dixon F. J., 1989. Immunogenetics, 29 (2) pp. 65-74.
 
Immunoglobulin kappa light chain variable region gene complex organization and immunoglobulin genes encoding anti-DNA autoantibodies in lupus mice
Kofler R., Strohal R., Balderas R. S., Johnson M. E., Noonan D. J., Duchosal M. A., Dixon F. J., Theofilopoulos A. N., 1988/09. Journal of Clinical Investigation, 82 (3) pp. 852-860.
 
The genetic origin of murine lupus-associated autoantibodies
Kofler R., Duchosal M. A., Johnson M. E., Aguado M. T., Strohal R., Kromer G., Fassler R., 1987/12. Immunology Letters, 16 (3-4) pp. 265-271.
 
Specificity and molecular characteristics of monoclonal IgM rheumatoid factors from arthritic and non-arthritic mice
Aguado M. T., Balderas R. S., Rubin R. L., Duchosal M. A., Kofler R., Birshtein B. K., Secher D. S., Dixon F. J., Theofilopoulos A. N., 1987/08. Journal of Immunology, 139 (4) pp. 1080-1087.
 
Nephrite interstitielle par abus d'analgesiques. [Interstitial nephritis as a result of analgesic abuse]
Duchosal M., 1984/04. Revue Médicale de la Suisse Romande, 104 (4) pp. 323-7.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University